Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hua

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Physical Review Letters|June 8, 2019
Phase Space Dynamics of a Plasma Wakefield Dechirper for Energy Spread ReductionY P Wu, J F Hua, Z Zhou, et al.
Physical Review Letters|February 4, 2014
Phase-space dynamics of ionization injection in plasma-based acceleratorsX L Xu, J F Hua, F Li, et al.
Physical Review Letters|September 27, 2017
Femtosecond Probing of Plasma Wakefields and Observation of the Plasma Wake Reversal Using a Relativistic Electron BunchC J Zhang, J F Hua, Y Wan, et al.
ESMO Open|August 3, 2022
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsE Borazanci, A M Schram, E Garralda, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Physical Review Letters|June 8, 2019
Phase Space Dynamics of a Plasma Wakefield Dechirper for Energy Spread ReductionY P Wu, J F Hua, Z Zhou, et al.
Physical Review Letters|February 4, 2014
Phase-space dynamics of ionization injection in plasma-based acceleratorsX L Xu, J F Hua, F Li, et al.
Physical Review Letters|September 27, 2017
Femtosecond Probing of Plasma Wakefields and Observation of the Plasma Wake Reversal Using a Relativistic Electron BunchC J Zhang, J F Hua, Y Wan, et al.
ESMO Open|August 3, 2022
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsE Borazanci, A M Schram, E Garralda, et al.
Pageof 9